Proto Labs (NYSE:PRLB) Announces Quarterly Earnings Results, Beats Estimates By $0.14 EPS

Key Points

• Proto Labs beat Q1 estimates with EPS of $0.54 versus a $0.40 consensus and revenue of $139.3M (up 10.4% YoY), and set Q2 guidance of $0.50–$0.58 EPS and $140M–$148M revenue.
• Operational momentum drove results: CNC machining posted strong double-digit growth, non-GAAP gross margin expanded to 46.2% with adjusted EBITDA margin at 16.3%, and the company holds about $158M in cash with zero debt.
• However, profitability and valuation raise caution — net margin (~3.98%) and ROE (~3.2%) remain low while the stock trades at a high P/E (around 74), leaving limited room for execution misses.

Proto Labs (NYSE:PRLB - Get Free Report) posted its quarterly earnings data on Friday. The industrial products company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14, Briefing.com reports. Proto Labs had a net margin of 3.98% and a return on equity of 3.19%. The firm had revenue of $139.34 million during the quarter, compared to analysts' expectations of $135.31 million. During the same quarter in the previous year, the company posted $0.33 EPS. Proto Labs's revenue was up 10.4% on a year-over-year basis. Proto Labs updated its Q2 2026 guidance to 0.500-0.580 EPS.

Here are the key takeaways from Proto Labs' conference call:

• Recorded a company-high quarter with $139.3M revenue (up 10.4% YoY), highest non-GAAP EPS in over five years at $0.54, $17.5M cash from operations, $158M cash/investments and zero debt.
• CNC machining was a major growth driver (17.6% CCY growth; U.S. CNC +23% YoY), led by aerospace, defense/space, satellites, drones and robotics, with targeted pricing actions executed.
• Margins and operating leverage improved materially — non-GAAP gross margin expanded to 46.2% (+140 bps) and adjusted EBITDA margin rose to 16.3%, driven by factory mix, pricing and volume.
• Management maintained full-year revenue guidance of 6%–8% and Q2 revenue of $140M–$148M (EPS $0.50–$0.58), citing a conservative stance given macro uncertainty despite the strong start.
• Strategic operational moves — a Europe reset (11% sequential growth), AS9100 certification in Europe, a Global Capability Center in India, and investments in injection molding and DMLS capacity — aim to accelerate production revenue and customer engagement.

Proto Labs Stock Up 0.4%

Shares of PRLB traded up $0.23 during trading hours on Friday, reaching $65.04. The stock had a trading volume of 443,326 shares, compared to its average volume of 177,663. Proto Labs has a 52 week low of $36.13 and a 52 week high of $68.91. The firm has a 50-day moving average of $60.29 and a 200 day moving average of $55.91. The company has a market cap of $1.55 billion, a P/E ratio of 73.91 and a beta of 1.31.

Key Stories Impacting Proto Labs

Here are the key news stories impacting Proto Labs this week:

• Positive Sentiment: Q1 beat — Proto Labs reported EPS of $0.54 vs. consensus $0.40 and revenue of $139.3M vs. $135.3M, driven by 10.4% year-over-year revenue growth. Protolabs Reports Financial Results for the First Quarter of 2026
• Positive Sentiment: Raised Q2 guidance — Management set Q2 FY2026 EPS guidance at $0.50–$0.58 (consensus ~$0.43) and revenue guidance of $140M–$148M (consensus ~$143.3M), signaling stronger near-term outlook. Q1 Slide Deck / Press Release
• Positive Sentiment: Operational strength — Company posted record quarterly revenue; CNC machining grew ~19.7% YoY and revenue per customer contact rose ~20.4%, suggesting stronger demand and pricing/volume mix improvement. Protolabs Reports Financial Results for the First Quarter of 2026
• Neutral Sentiment: Earnings call & materials available — Management commentary and the slide deck provide color on end-market trends, customer mix and margin drivers; investors can review the transcript and presentation for guidance detail. Q1 2026 Earnings Call Transcript Q1 Results Presentation
• Negative Sentiment: Profitability & valuation caveats — Net margin remains modest (~3.98%) and return on equity is low (~3.2%), while the stock trades at a high P/E (~74), leaving limited margin for execution misses or demand slowdowns.

Analyst Ratings Changes

PRLB has been the subject of several research analyst reports. Zacks Research cut shares of Proto Labs from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 10th. Weiss Ratings restated a "hold (c-)" rating on shares of Proto Labs in a research report on Thursday, January 22nd. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $53.33.

Insider Activity at Proto Labs

In related news, insider Michael R. Kenison sold 2,500 shares of the company's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $60.00, for a total value of $150,000.00. Following the completion of the sale, the insider owned 34,526 shares in the company, valued at $2,071,560. This represents a 6.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Proto Labs

A number of large investors have recently made changes to their positions in the company. Bank of Montreal Can acquired a new position in shares of Proto Labs during the 4th quarter worth about $202,000. Polen Capital Management LLC acquired a new position in shares of Proto Labs during the 4th quarter worth about $210,000. Cerity Partners LLC acquired a new position in shares of Proto Labs during the 4th quarter worth about $214,000. Prelude Capital Management LLC acquired a new position in shares of Proto Labs during the 3rd quarter worth about $264,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Proto Labs by 28.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,456 shares of the industrial products company's stock worth $273,000 after buying an additional 1,215 shares during the last quarter. Institutional investors own 84.54% of the company's stock.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.